103 related articles for article (PubMed ID: 24623318)
1. The flavonols quercetin and 3',4'-dihydroxyflavonol reduce platelet function and delay thrombus formation in a model of type 1 diabetes.
Mosawy S; Jackson DE; Woodman OL; Linden MD
Diab Vasc Dis Res; 2014 May; 11(3):174-81. PubMed ID: 24623318
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of platelet-mediated arterial thrombosis and platelet granule exocytosis by 3',4'-dihydroxyflavonol and quercetin.
Mosawy S; Jackson DE; Woodman OL; Linden MD
Platelets; 2013; 24(8):594-604. PubMed ID: 23249183
[TBL] [Abstract][Full Text] [Related]
3. Treatment with quercetin and 3',4'-dihydroxyflavonol inhibits platelet function and reduces thrombus formation in vivo.
Mosawy S; Jackson DE; Woodman OL; Linden MD
J Thromb Thrombolysis; 2013 Jul; 36(1):50-7. PubMed ID: 23070586
[TBL] [Abstract][Full Text] [Related]
4. 3',4'-Dihydroxyflavonol restores endothelium-dependent relaxation in small mesenteric artery from rats with type 1 and type 2 diabetes.
Leo CH; Hart JL; Woodman OL
Eur J Pharmacol; 2011 Jun; 659(2-3):193-8. PubMed ID: 21453697
[TBL] [Abstract][Full Text] [Related]
5. Vascular and anti-oxidant actions of flavonols and flavones.
Woodman OL; Chan ECh
Clin Exp Pharmacol Physiol; 2004 Nov; 31(11):786-90. PubMed ID: 15566394
[TBL] [Abstract][Full Text] [Related]
6. Acid sphingomyelinase regulates platelet cell membrane scrambling, secretion, and thrombus formation.
Münzer P; Borst O; Walker B; Schmid E; Feijge MA; Cosemans JM; Chatterjee M; Schmidt EM; Schmidt S; Towhid ST; Leibrock C; Elvers M; Schaller M; Seizer P; Ferlinz K; May AE; Gulbins E; Heemskerk JW; Gawaz M; Lang F
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):61-71. PubMed ID: 24233488
[TBL] [Abstract][Full Text] [Related]
7. Pentamethylquercetin (PMQ) reduces thrombus formation by inhibiting platelet function.
Liang ML; Da XW; He AD; Yao GQ; Xie W; Liu G; Xiang JZ; Ming ZY
Sci Rep; 2015 Jun; 5():11142. PubMed ID: 26059557
[TBL] [Abstract][Full Text] [Related]
8. 3',4'-Dihydroxyflavonol prevents diabetes-induced endothelial dysfunction in rat aorta.
Woodman OL; Malakul W
Life Sci; 2009 Jul; 85(1-2):54-9. PubMed ID: 19409910
[TBL] [Abstract][Full Text] [Related]
9. Modulation of nicotinamide adenine dinucleotide phosphate oxidase expression and function by 3',4'-dihydroxyflavonol in phagocytic and vascular cells.
Jiang F; Guo N; Dusting GJ
J Pharmacol Exp Ther; 2008 Jan; 324(1):261-9. PubMed ID: 17916758
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of platelet nitric oxide production by nebivolol prevents thrombosis.
Momi S; Caracchini R; Falcinelli E; Evangelista S; Gresele P
Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):820-9. PubMed ID: 24558107
[TBL] [Abstract][Full Text] [Related]
11. Ingestion of quercetin inhibits platelet aggregation and essential components of the collagen-stimulated platelet activation pathway in humans.
Hubbard GP; Wolffram S; Lovegrove JA; Gibbins JM
J Thromb Haemost; 2004 Dec; 2(12):2138-45. PubMed ID: 15613018
[TBL] [Abstract][Full Text] [Related]
12. Effects of quercetin on aggregation and intracellular free calcium of platelets.
Xiao D; Gu ZL; Bai JP; Wang Z
Zhongguo Yao Li Xue Bao; 1995 May; 16(3):223-6. PubMed ID: 7660815
[TBL] [Abstract][Full Text] [Related]
13. Platelets possess and require an active protein palmitoylation pathway for agonist-mediated activation and in vivo thrombus formation.
Sim DS; Dilks JR; Flaumenhaft R
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1478-85. PubMed ID: 17303775
[TBL] [Abstract][Full Text] [Related]
14. Effect of chronic treatment with acetylsalicylic acid and clopidogrel on atheroprogression and atherothrombosis in ApoE-deficient mice in vivo.
Schulz C; Konrad I; Sauer S; Orschiedt L; Koellnberger M; Lorenz R; Walter U; Massberg S
Thromb Haemost; 2008 Jan; 99(1):190-5. PubMed ID: 18217153
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of Bulnesia sarmienti aqueous extract on agonist-induced platelet activation and thrombus formation involves mitogen-activated protein kinases.
Kamruzzaman SM; Endale M; Oh WJ; Park SC; Kim KS; Hong JH; Kwak YS; Yun BS; Rhee MH
J Ethnopharmacol; 2010 Aug; 130(3):614-20. PubMed ID: 20558266
[TBL] [Abstract][Full Text] [Related]
16. Neferine exerts its antithrombotic effect by inhibiting platelet aggregation and promoting dissociation of platelet aggregates.
Zhou YJ; Xiang JZ; Yuan H; Liu H; Tang Q; Hao HZ; Yin Z; Wang J; Ming ZY
Thromb Res; 2013 Aug; 132(2):202-10. PubMed ID: 23773522
[TBL] [Abstract][Full Text] [Related]
17. Prevention of occlusive arterial thrombus formation by a single loading dose of prasugrel suppresses neointimal hyperplasia in mice.
Ohno K; Tomizawa A; Jakubowski JA; Mizuno M; Sugidachi A
Thromb Res; 2015 Dec; 136(6):1245-51. PubMed ID: 26489728
[TBL] [Abstract][Full Text] [Related]
18. Tangeretin regulates platelet function through inhibition of phosphoinositide 3-kinase and cyclic nucleotide signaling.
Vaiyapuri S; Ali MS; Moraes LA; Sage T; Lewis KR; Jones CI; Gibbins JM
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2740-9. PubMed ID: 24135020
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of platelet-rich arterial thrombus in vivo: acute antithrombotic effect of intravenous HMG-CoA reductase therapy.
Obi C; Wysokinski W; Karnicki K; Owen WG; McBane RD
Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1271-6. PubMed ID: 19667107
[TBL] [Abstract][Full Text] [Related]
20. Platelet activation patterns are different in mouse models of diabetes and chronic inhibition of nitric oxide synthesis.
Rozalski M; Kassassir H; Siewiera K; Klepacka A; Sychowski R; Watala C
Thromb Res; 2014 Jun; 133(6):1097-104. PubMed ID: 24731558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
